Clinical potential of methylphenidate in the treatment of cocaine addiction: a review of the current evidence

References

• United Nations Office on Drugs and Crime (UNODC)World Drug Report 2013New YorkUnited Nations2013
   Google Scholar
• United Nations Office on Drugs and Crime (UNODC)World Drug Report 2012New YorkUnited Nations2012
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)European drug report 2014: Trends and developmentsLisbonEMCDDA2014 Available from: http://www.emcdda.europa.eu/publications/edr/trends-developments/2014Accessed May 1, 2015
   Google Scholar
• OrtCvan NuijsALBersetJDSpatial differences and temporal changes in illicit drug use in Europe quantified by wastewater analysisAddiction20141091338135224861844
   PubMed Web of Science ®Google Scholar
• DegenhardtLHallWExtent of illicit drug use and dependence, and their contribution to the global burden of diseaseLancet2012379557022225671
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)Selected Issue 2007: Cocaine and Crack Cocaine: A Growing Public Health IssueLuxembourgOffice for Official Publications of the European Communities2007
   Google Scholar
• KayeSDarkeSInjecting and non-injecting cocaine use in Sydney, Australia: physical and psychological morbidityDrug Alcohol Rev20042339139815763743
   PubMed Web of Science ®Google Scholar
• MacdonaldSAnglin-BodrugKMannREInjury risk associated with cannabis and cocaine useDrug Alcohol Depend2003729911514636965
   PubMed Web of Science ®Google Scholar
• MarajSFigueredoVMLynn MorrisDCocaine and the heartClin Cardiol20103326426920513064
   PubMed Web of Science ®Google Scholar
• MarzukPMTardiffKLeonACFatal injuries after cocaine use as a leading cause of death among young adults in New York CityN Engl J Med1995332175317577760893
   PubMed Web of Science ®Google Scholar
• QureshiAIChaudhrySASuriMFCocaine use and the likelihood of cardiovascular and all-cause mortality: data from the Third National Health and Nutrition Examination Survey Mortality Follow-up StudyJ Vasc Interv Neurol20147768224920992
   PubMedGoogle Scholar
• TardiffKMarzukPMLeonACPorteraLWeinerCViolence by patients admitted to a private psychiatric hospitalAm J Psychiatry199715488938988964
   PubMed Web of Science ®Google Scholar
• BarrioGMolistGde la FuenteLItinere Working GroupMortality in a cohort of young primary cocaine users: controlling the effect of the riskiest drug-use behaviorsAddict Behav2013381601160423254204
   PubMed Web of Science ®Google Scholar
• WagnerFAAnthonyJCFrom first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcoholNeuropsychopharmacology20022647948811927172
   PubMed Web of Science ®Google Scholar
• DegenhardtLBaxterAJLeeYYThe global epidemiology and burden of psychostimulant dependence: findings from the Global Burden of Disease Study 2010Drug Alcohol Depend2014137364724559607
   PubMed Web of Science ®Google Scholar
• van de GlindGKonsteniusMKoeterMWIASP Research GroupVariability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteriaDrug Alcohol Depend201413415816624156882
   PubMed Web of Science ®Google Scholar
• WilensTEBiedermanJSpencerTJFrancesRJComorbidity of attention-deficit hyperactivity and psychoactive substance use disordersHosp Community Psychiatry1994454214234358045536
   PubMedGoogle Scholar
• ChronisAMLaheyBBPelhamWEJrKippHLBaumannBLLeeSSPsychopathology and substance abuse in parents of young children with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry2003421424143214627877
   PubMed Web of Science ®Google Scholar
• SchuckitMASmithTLAn 8-year follow-up of 450 sons of alcoholic and control subjectsArch Gen Psychiatry1996532022108611056
   PubMed Web of Science ®Google Scholar
• CunhaPJGonçalvesPDOmettoMExecutive cognitive dysfunction and ADHD in cocaine dependence: searching for a common cognitive endophenotype for addictive disordersFront Psychiatry2013412624155725
   PubMedGoogle Scholar
• VolkowNDWangGJKollinsSHEvaluating dopamine reward pathway in ADHD: clinical implicationsJAMA20093021084109119738093
   PubMed Web of Science ®Google Scholar
• YoungSEFriedmanNPMiyakeABehavioral disinhibition: liability for externalizing spectrum disorders and its genetic and environmental relation to response inhibition across adolescenceJ Abnorm Psychol200911811713019222319
   PubMed Web of Science ®Google Scholar
• KhantzianEJAn extreme case of cocaine dependence and marked improvement with methylphenidate treatmentAm J Psychiatry19831407847856846640
   PubMed Web of Science ®Google Scholar
• PrendergastMPodusDFinneyJGreenwellLRollJContingency management for treatment of substance use disorders: a meta-analysisAddiction20061011546156017034434
   PubMed Web of Science ®Google Scholar
• WeissLMPetryNMSubstance abuse treatment patients with early onset cocaine use respond as well to contingency management interventions as those with later onset cocaine useJ Subst Abuse Treat20144714615024865619
   PubMed Web of Science ®Google Scholar
• EpsteinDHHawkinsWECoviLUmbrichtAPrestonKLCognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-upPsychol Addict Behav200317738212665084
   PubMed Web of Science ®Google Scholar
• CarrollKMOnkenLSBehavioral therapies for drug abuseAm J Psychiatry20051621452146016055766
   PubMed Web of Science ®Google Scholar
• DutraLStathopoulouGBasdenSLLeyroTMPowersMBOttoMWA meta-analytic review of psychosocial interventions for substance use disordersAm J Psychiatry200816517918718198270
   PubMed Web of Science ®Google Scholar
• BrensilverMHeinzerlingKGShoptawSPharmacotherapy of amphetamine-type stimulant dependence: an updateDrug Alcohol Rev20133244946023617468
   PubMed Web of Science ®Google Scholar
• AharonovichEHasinDSBrooksACLiuXBisagaANunesEVCognitive deficits predict low treatment retention in cocaine dependent patientsDrug Alcohol Depend20068131332216171953
   PubMed Web of Science ®Google Scholar
• Dürsteler-MacFarlandKMFarronatoNSStrasserJA randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescriptionJ Clin Psychopharmacol20133310410823277248
   PubMed Web of Science ®Google Scholar
• AharonovichEAmrheinPCBisagaANunesEVHasinDSCognition, commitment language, and behavioral change among cocaine-dependent patientsPsychol Addict Behav20082255756219071981
   PubMed Web of Science ®Google Scholar
• CarrollKMNichCBallSAPractice makes progress? Homework assignments and outcome in treatment of cocaine dependenceJ Consult Clin Psychol20057374975516173864
   PubMed Web of Science ®Google Scholar
• GonzalezVMSchmitzJMDeLauneKAThe role of homework in cognitive-behavioral therapy for cocaine dependenceJ Consult Clin Psychol20067463363716822120
   PubMed Web of Science ®Google Scholar
• CarrollKMFentonLRBallSAEfficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trialArch Gen Psychiatry20046126427214993114
   PubMed Web of Science ®Google Scholar
• VocciFJMontoyaIDPsychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependenceCurr Opin Psychiatry20092226326819307968
   PubMed Web of Science ®Google Scholar
• AmatoLDavoliMPerucciCAFerriMFaggianoFMattickRPAn overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and researchJ Subst Abuse Treat20052832132915925266
   PubMed Web of Science ®Google Scholar
• KreekMJVocciFJHistory and current status of opioid maintenance treatments: blending conference sessionJ Subst Abuse Treat2002239310512220607
   PubMed Web of Science ®Google Scholar
• AubinHJLuquiensABerlinIPharmacotherapy for smoking cessation: pharmacological principles and clinical practiceBr J Clin Pharmacol20147732433623488726
   PubMed Web of Science ®Google Scholar
• BerrettiniWHLermanCEPharmacotherapy and pharmacogenetics of nicotine dependenceAm J Psychiatry20051621441145116055765
   PubMed Web of Science ®Google Scholar
• GorelickDAGardnerELXiZXAgents in development for the management of cocaine abuseDrugs2004641547157315233592
   PubMed Web of Science ®Google Scholar
• RushCRStoopsWWAgonist replacement therapy for cocaine dependence: a translational reviewFuture Med Chem2012424526522300101
   PubMed Web of Science ®Google Scholar
• MarianiJJLevinFRPsychostimulant treatment of cocaine dependencePsychiatr Clin North Am20123542543922640764
   PubMed Web of Science ®Google Scholar
• StoopsWWRushCRAgonist replacement for stimulant dependence: a review of clinical researchCurr Pharm Des2013197026703523574440
   PubMed Web of Science ®Google Scholar
• RitzMCLambRJGoldbergSRKuharMJCocaine receptors on dopamine transporters are related to self-administration of cocaineScience1987237121912232820058
   PubMed Web of Science ®Google Scholar
• Di ChiaraGImperatoADrugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving ratsProc Natl Acad Sci U S A198885527452782899326
   PubMed Web of Science ®Google Scholar
• KuharMJRitzMCBojaJWThe dopamine hypothesis of the reinforcing properties of cocaineTrends Neurosci1991142993021719677
   PubMed Web of Science ®Google Scholar
• CalipariESFerrisMJMelchiorJRMethylphenidate and cocaine self-administration produce distinct dopamine terminal alterationsAddict Biol20141914515522458761
   PubMed Web of Science ®Google Scholar
• MartinezDNarendranRFoltinRWAmphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaineAm J Psychiatry200716462262917403976
   PubMed Web of Science ®Google Scholar
• McIntoshSHowellLHembySEDopaminergic dysregulation in pre-frontal cortex of rhesus monkeys following cocaine self-administrationFront Psychiatry201348823970867
   PubMedGoogle Scholar
• HaileCNKostenTRPharmacotherapy for stimulant-related disordersCurr Psychiatry Rep20131541524142188
   PubMed Web of Science ®Google Scholar
• WeinshenkerDSchroederJPThere and back again: a tale of norepinephrine and drug addictionNeuropsychopharmacology2007321433145117164822
   PubMed Web of Science ®Google Scholar
• KalivasPWVolkowNDNew medications for drug addiction hiding in glutamatergic neuroplasticityMol Psychiatry20111697498621519339
   PubMed Web of Science ®Google Scholar
• RochaBAStimulant and reinforcing effects of cocaine in monoamine transporter knockout miceEur J Pharmacol200347910711514612142
   PubMed Web of Science ®Google Scholar
• MortonWAStocktonGGMethylphenidate abuse and psychiatric side effectsPrim Care Companion J Clin Psychiatry2000215916415014637
   PubMedGoogle Scholar
• LeonardBEMcCartanDWhiteJKingDJMethylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effectsHum Psychopharmacol20041915118015079851
   PubMed Web of Science ®Google Scholar
• EpsteinTPatsopoulosNAWeiserMImmediate-release methylpheni-date for attention deficit hyperactivity disorder (ADHD) in adultsCochrane Database Syst Rev20149CD00504125230710
   PubMed Web of Science ®Google Scholar
• CollinsSLLevinFRFoltinRWKleberHDEvansSMResponse to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHDDrug Alcohol Depend20068215816716213109
   PubMed Web of Science ®Google Scholar
• GrabowskiJRoacheJDSchmitzJMRhoadesHCresonDKorszunAReplacement medication for cocaine dependence: methylphenidateJ Clin Psychopharmacol1997174854889408812
   PubMed Web of Science ®Google Scholar
• WinhusenTSomozaESingalBMMethylphenidate and cocaine: a placebo-controlled drug interaction studyPharmacol Biochem Behav200685293816916538
   PubMed Web of Science ®Google Scholar
• SchubinerHSaulesKKArfkenCLDouble-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependenceExp Clin Psychopharmacol20021028629412233989
   PubMed Web of Science ®Google Scholar
• MehtaMAOwenAMSahakianBJMavaddatNPickardJDRobbinsTWMethylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brainJ Neurosci200020RC6510704519
   PubMed Web of Science ®Google Scholar
• MoellerSJHonorioJTomasiDMethylphenidate enhances executive function and optimizes prefrontal function in both health and cocaine addictionCereb Cortex20142464365323162047
   PubMed Web of Science ®Google Scholar
• CarmackSABlockCLHowellKKAnagnostarasSGMethylphenidate enhances acquisition and retention of spatial memoryNeurosci Lett2014567455024680747
   PubMed Web of Science ®Google Scholar
• LiCSMorganPTMatuskeyDBiological markers of the effects of intravenous methylphenidate on improving inhibitory control in cocaine-dependent patientsProc Natl Acad Sci U S A2010107144551445920660731
   PubMed Web of Science ®Google Scholar
• SofuogluMDeVitoEEWatersAJCarrollKMCognitive enhancement as a treatment for drug addictionsNeuropharmacology20136445246322735770
   PubMed Web of Science ®Google Scholar
• AngaritaGACanavanSVForseliusEBessetteAPittmanBMorganPTAbstinence-related changes in sleep during treatment for cocaine dependenceDrug Alcohol Depend201413434334724315572
   PubMed Web of Science ®Google Scholar
• KollinsSHMacDonaldEKRushCRAssessing the abuse potential of methylphenidate in nonhuman and human subjects: a reviewPharmacol Biochem Behav20016861162711325419
   PubMed Web of Science ®Google Scholar
• ParranTVJrJasinskiDRIntravenous methylphenidate abuse. Prototype for prescription drug abuseArch Intern Med19911517817831849397
   PubMed Web of Science ®Google Scholar
• StoopsWWGlaserPEFillmoreMTRushCRReinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humansJ Psychopharmacol20041853454315582920
   PubMed Web of Science ®Google Scholar
• KollinsSHRushCRPazzagliaPJAliJAComparison of acute behavioral effects of sustained-release and immediate-release methylphenidateExp Clin Psychopharmacol199863673749861551
   PubMed Web of Science ®Google Scholar
• KollinsSHComparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patientJ Clin Psychiatry200364Suppl 11141814529325
   PubMed Web of Science ®Google Scholar
• SembowerMAErtischekMDBuchholtzCDasguptaNSchnollSHSurveillance of diversion and nonmedical use of extended-release prescription amphetamine and oral methylphenidate in the United StatesJ Addict Dis201332263823480245
   PubMed Web of Science ®Google Scholar
• KollinsSHAbuse liability of medications used to treat attention-deficit/ hyperactivity disorder (ADHD)Am J Addict200716Suppl 13542 quiz 43–3417453605
   PubMed Web of Science ®Google Scholar
• MaierLJLiechtiMEHerzigFSchaubMPTo dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university studentsPLoS One20138e7796724236008
   PubMed Web of Science ®Google Scholar
• RitzMCKuharMJRelationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaineJ Pharmacol Exp Ther1989248101010172703961
   PubMed Web of Science ®Google Scholar
• FleckensteinAEVolzTJRiddleELGibbJWHansonGRNew insights into the mechanism of action of amphetaminesAnnu Rev Pharmacol Toxicol20074768169817209801
   PubMed Web of Science ®Google Scholar
• RothmanRBBaumannMHDerschCMAmphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotoninSynapse200139324111071707
   PubMed Web of Science ®Google Scholar
• SchmittKCRothmanRBReithMENonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substratesJ Pharmacol Exp Ther201334621023568856
   PubMed Web of Science ®Google Scholar
• ChallmanTDLipskyJJMethylphenidate: its pharmacology and usesMayo Clin Proc20007571172110907387
   PubMed Web of Science ®Google Scholar
• GatleySJPanDChenRChaturvediGDingYSAffinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transportersLife Sci1996582312398786705
   PubMed Web of Science ®Google Scholar
• BymasterFPKatnerJSNelsonDLAtomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorderNeuropsychopharmacology20022769971112431845
   PubMed Web of Science ®Google Scholar
• HealDJGosdenJSmithSLDopamine reuptake transporter (DAT) “inverse agonism” – a novel hypothesis to explain the enigmatic pharmacology of cocaineNeuropharmacology201487194024953830
   PubMed Web of Science ®Google Scholar
• VolkowNDFowlerJSGatleySJComparable changes in synaptic dopamine induced by methylphenidate and by cocaine in the baboon brainSynapse199931596610025684
   PubMed Web of Science ®Google Scholar
• VolkowNDFowlerJSWangGJImaging studies on the role of dopamine in cocaine reinforcement and addiction in humansJ Psychopharmacol19991333734510667609
   PubMed Web of Science ®Google Scholar
• VolkowNDSwansonJMVariables that affect the clinical use and abuse of methylphenidate in the treatment of ADHDAm J Psychiatry20031601909191814594733
   PubMed Web of Science ®Google Scholar
• VolkowNDWangGJFowlerJSMethylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brainLife Sci199965PL7PL1210403500
   PubMed Web of Science ®Google Scholar
• VolkowNDDingYSFowlerJSIs methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brainArch Gen Psychiatry1995524564637771915
   PubMed Web of Science ®Google Scholar
• VolkowNDFowlerJSWangGJDingYSGatleySJRole of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studiesEur Neuropsychopharmacol20021255756612468018
   PubMed Web of Science ®Google Scholar
• VolkowNDWangGJFowlerJSRelationship between psychostimulant-induced “high” and dopamine transporter occupancyProc Natl Acad Sci U S A19969310388103928816810
   PubMed Web of Science ®Google Scholar
• BalsterRLSchusterCRFixed-interval schedule of cocaine reinforcement: effect of dose and infusion durationJ Exp Anal Behav1973201191294197505
   PubMed Web of Science ®Google Scholar
• VolkowNDWangGJFowlerJSBlockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of “high”J Pharmacol Exp Ther199928814209862747
   PubMed Web of Science ®Google Scholar
• VolkowNDWangGFowlerJSTherapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brainJ Neurosci200121RC12111160455
   PubMed Web of Science ®Google Scholar
• VolkowNDWangGJFowlerJSDopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidateAm J Psychiatry1998155132513319766762
   PubMed Web of Science ®Google Scholar
• MarusichJABeckmannJSGipsonCDBardoMTMethylphenidate as a reinforcer for rats: contingent delivery and intake escalationExp Clin Psychopharmacol20101825726620545390
   PubMed Web of Science ®Google Scholar
• BergmanJMadrasBKJohnsonSESpealmanRDEffects of cocaine and related drugs in nonhuman primates. III Self-administration by squirrel monkeysJ Pharmacol Exp Ther19892511501552529365
   PubMed Web of Science ®Google Scholar
• LiSMCampbellBLKatzJLInteractions of cocaine with dopamine uptake inhibitors or dopamine releasers in rats discriminating cocaineJ Pharmacol Exp Ther20063171088109616478825
   PubMed Web of Science ®Google Scholar
• ThanosPKMichaelidesMBenvenisteHWangGJVolkowNDEffects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodentsPharmacol Biochem Behav20078742643317599397
   PubMed Web of Science ®Google Scholar
• ChaitLDReinforcing and subjective effects of methylphenidate in humansBehav Pharmacol1994528128811224277
   PubMed Web of Science ®Google Scholar
• KollinsSHEnglishJRobinsonRHallyburtonMChrismanAKReinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD)Psychopharmacology (Berl)2009204738319104775
   PubMed Web of Science ®Google Scholar
• RushCRKollinsSHPazzagliaPJDiscriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humansExp Clin Psychopharmacol1998632449526144
   PubMed Web of Science ®Google Scholar
• RushCREssmanWDSimpsonCABakerRWReinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humansJ Clin Psychopharmacol20012127328611386490
   PubMed Web of Science ®Google Scholar
• SchmidYHysekCMSimmlerLDCrockettMJQuednowBBLiechtiMEDifferential effects of MDMA and methylphenidate on social cognitionJ Psychopharmacol20142884785625052243
   PubMed Web of Science ®Google Scholar
• RushCRBakerRWBehavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusersExp Clin Psychopharmacol20019597311519636
   PubMed Web of Science ®Google Scholar
• StoopsWWGlaserPERushCRReinforcing, subject-rated, and physiological effects of intranasal methylphenidate in humans: a dose-response analysisDrug Alcohol Depend20037117918612927656
   PubMed Web of Science ®Google Scholar
• WangGJVolkowNDHitzemannRJBehavioral and cardiovascular effects of intravenous methylphenidate in normal subjects and cocaine abusersEur Addict Res199734954
   Web of Science ®Google Scholar
• RoacheJDGrabowskiJSchmitzJMCresonDLRhoadesHMLaboratory measures of methylphenidate effects in cocaine-dependent patients receiving treatmentJ Clin Psychopharmacol200020616810653210
   PubMed Web of Science ®Google Scholar
• KhantzianEJGawinFKleberHDRiordanCEMethylphenidate (Ritalin) treatment of cocaine dependence – a preliminary reportJ Subst Abuse Treat198411071126536756
   PubMedGoogle Scholar
• ImbertBLabruneNLanconCSimonNUse of extended-release methylphenidate (concerta) in treatment of cocaine dependence in a patient presenting with attention deficit hyperactivity disorderJ Neuropsychiatry Clin Neurosci201426E49E5025093790
   PubMed Web of Science ®Google Scholar
• MarianiJJKhantzianEJLevinFRThe self-medication hypothesis and psychostimulant treatment of cocaine dependence: an updateAm J Addict20142318919325187055
   PubMed Web of Science ®Google Scholar
• GawinFRiordanCKleberHMethylphenidate treatment of cocaine abusers without attention deficit disorder: a negative reportAm J Drug Alcohol Abuse1985111931974091158
   PubMed Web of Science ®Google Scholar
• LevinFREvansSMMcDowellDMKleberHDMethylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot studyJ Clin Psychiatry1998593003059671342
   PubMed Web of Science ®Google Scholar
• CastanedaRSussmanNLevyRTrujilloMA treatment algorithm for attention deficit hyperactivity disorder in cocaine-dependent adults: a one-year private practice study with long-acting stimulants, fluoxetine, and bupropionSubst Abus199920597112511821
   PubMedGoogle Scholar
• SomozaECWinhusenTMBridgeTPAn open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorderJ Addict Dis200423779215077842
   PubMed Web of Science ®Google Scholar
• SzobotCMShihMCSchaeferTMethylphenidate DAT binding in adolescents with attention-deficit/hyperactivity disorder comorbid with substance use disorder – a single photon emission computed tomography with [Tc(99m)]TRODAT-1 studyNeuroimage2008401195120118282769
   PubMed Web of Science ®Google Scholar
• SchubinerHSubstance abuse in patients with attention-deficit hyperactivity disorder: therapeutic implicationsCNS Drugs20051964365516097847
   PubMed Web of Science ®Google Scholar
• LevinFREvansSMBrooksDJKalbagASGarawiFNunesEVTreatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placeboDrug Alcohol Depend20068113714816102908
   PubMed Web of Science ®Google Scholar
• LevinFREvansSMBrooksDJGarawiFTreatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placeboDrug Alcohol Depend200787202916930863
   PubMed Web of Science ®Google Scholar
• CzotyPWMartelleSEGouldRWNaderMAEffects of chronic methylphenidate on cocaine self-administration under a progressive-ratio schedule of reinforcement in rhesus monkeysJ Pharmacol Exp Ther201334537438223579044
   PubMed Web of Science ®Google Scholar
• TiihonenJKuoppasalmiKFöhrJA comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependenceAm J Psychiatry200716416016217202560
   PubMed Web of Science ®Google Scholar
• MartinezDCarpenterKMLiuFImaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatmentAm J Psychiatry201116863464121406463
   PubMed Web of Science ®Google Scholar
• GoldsteinRZVolkowNDOral methylphenidate normalizes cingulate activity and decreases impulsivity in cocaine addiction during an emotionally salient cognitive taskNeuropsychopharmacology20113636636721116260
   PubMed Web of Science ®Google Scholar
• GoldsteinRZWoicikPAMaloneyTOral methylphenidate normalizes cingulate activity in cocaine addiction during a salient cognitive taskProc Natl Acad Sci U S A2010107166671667220823246
   PubMed Web of Science ®Google Scholar
• KonovaABMoellerSJTomasiDVolkowNDGoldsteinRZEffects of methylphenidate on resting-state functional connectivity of the mesocorticolimbic dopamine pathways in cocaine addictionJAMA Psychiatry20137085786823803700
   PubMed Web of Science ®Google Scholar
• MatuskeyDLuoXZhangSMethylphenidate remediates error-preceding activation of the default mode brain regions in cocaine-addicted individualsPsychiatry Res201321411612123973363
   PubMed Web of Science ®Google Scholar
• VolkowNDWangGJTomasiDMethylphenidate attenuates limbic brain inhibition after cocaine-cues exposure in cocaine abusersPLoS One20105e1150920634975
   PubMed Web of Science ®Google Scholar
• HaileCNKostenTRThe potential of pharmacogenomics to treat drug addictionPharmacogenomics2009101883188619958085
   PubMed Web of Science ®Google Scholar
• KostenTRWuGHuangWPharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylaseBiol Psychiatry20137321922422906516
   PubMed Web of Science ®Google Scholar
• DeVitoEEBabuscioTANichCBallSACarrollKMGender differences in clinical outcomes for cocaine dependence: randomized clinical trials of behavioral therapy and disulfiramDrug Alcohol Depend201414515616725457739
   PubMed Web of Science ®Google Scholar
• AnkerJJCarrollMEFemales are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormonesNeillJCKulkarniJBiological Basis of Sex Differences in PsychopharmacologyHeidelbergSpringer-Verlag Berlin Heidelberg20117396
   Google Scholar